SH
Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
$0.12 +0.00% (+$0.00)
Market Cap ¥7.27B
P/E Ratio 41.55x
Div. Yield 1.17%
ROE 3.37%
Bulios Fair Price
$0.12
0.0% downside
Current Price
$0.12
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SHPHF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
7/9Valuation
53 /100
Fair P/E 41.55x
EV/EBITDA 10.42x
P/S 2.85x
Growth
51 /100
Stable Rev. growth 5.35%
Book val. growth 7.30%
EPS growth N/A
Profitability
48 /100
Moderate Gross margin 68.83%
Net margin 6.86%
Op. margin 14.99%
Quality
12 /100
Poor ROIC 2.08%
ROE 3.37%
ROA 1.50%
Debt
83 /100
Low Debt/Equity 0.16x
Current ratio 1.80x
Int. coverage 1.95x
Stability
41 /100
Moderate Beta 0.89x
Rev. volatility 24.81%
EPS volatility 258.84%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SHPHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Wei Cheng Guo
Employees
2,843
Headquarters
Hong Kong
Upcoming events
01 APR
Earnings
Upcoming earnings report